Mordor Intelligence has published a new report on critical ischemia treatment market offering a comprehensive analysis of trends, growth drivers, and future projections.

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

Exercise-induced ST-segment depression ≥ 1.0 mm ≥ 1 episode of reversible ST-segment depression ≥ 1.0 mm during 48-hour ambulatory electrocardiographic (ECG) monitoring of routine activities. Patients ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Treatment is determined by the type of stroke suffered (i.e., ischemic or hemorrhagic) rather than the anatomic location. Symptoms referable to the anterior circulation — specifically, anterior and ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, ...

The PSD-95 inhibitor also had a favorable safety profile in phase III trial ...

Please provide your email address to receive an email when new articles are posted on . PARK CITY, Utah — Outcomes from the phase 1/2a HORNBILL study indicate a potential disease-modifying effect of ...

Mesenteric ischemia, or small bowel ischemia, involves a blockage of blood flow to the small intestine. Symptoms include pain and bloating. It often results from blood clots or atherosclerosis.

Alternate treatment options Although thrombolytics can produce dramatic responses for those patients who are eligible to receive treatment, the actual number of people who qualify for this therapy is ...